Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma.
about
Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studiesSingle nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomesAutophagy, autophagy-associated adaptive immune responses and its role in hematologic malignanciesIL-1β induced HIF-1α inhibits the differentiation of human FOXP3+ T cells.Inhibition of HIF-1α by PX-478 suppresses tumor growth of esophageal squamous cell cancer in vitro and in vivo.Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma.The era of bioengineering: how will this affect the next generation of cancer immunotherapy?Combinatorial strategies for the induction of immunogenic cell death.Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer.The hypoxic tumor microenvironment: A driving force for breast cancer progression.Rituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma.Inhibition of Hif1α prevents both trauma-induced and genetic heterotopic ossificationLysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus.The role of hypoxia in pancreatic cancer: a potential therapeutic target?Targeting cancer cell mitochondria as a therapeutic approach: recent updates.Cellular and molecular aspects of pancreatic cancer.CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells.Addressing intra-tumoral heterogeneity and therapy resistance.Editorial: Immunogenic Cell Death in Cancer: From Benchside Research to Bedside Reality.In vivo functional dissection of a context-dependent role for Hif1α in pancreatic tumorigenesis.The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth.Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells.The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.Metabolic Regulation of T Cell Immunity.HIF-1 maintains a functional relationship between pancreatic cancer cells and stromal fibroblasts by upregulating expression and secretion of Sonic hedgehog.p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulationLiposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response
P2860
Q26774636-1543F9FC-0BC8-4799-95D4-0D3D4B743924Q27853336-F4952497-BF9F-4085-A535-10E891FD8380Q28072922-938D9B06-E57B-45CB-92BD-0709AB8DD922Q33673786-9FCBB5E3-1A86-427A-97C2-5CE1E990618FQ33733037-A0623C7C-A01C-4414-B227-ECA59D0A2AFDQ33753714-62BD3614-F29F-4762-9C5E-A9B796F47B70Q33815087-464BA50C-C01F-4357-B9AB-F0C7D92A5EDCQ35535140-B0E569CF-7E21-42EA-B1F9-6FD1C476D160Q35832193-1346A7CD-3E9C-41CD-AD2B-061105E0BAF7Q36368931-8321A726-3B31-4929-B460-C83E0475BA74Q36413919-B5EE21DA-88E4-440F-952B-3BEFF1B9403EQ36498232-647B03A6-CCC6-44D2-A5E0-6F14FD2C9F17Q37437259-61A022BC-3300-445F-B307-88508D09DE97Q38631404-5017DBC8-63D2-4A62-BF18-621C7333154FQ38668524-FD2AA0D7-E2BC-4335-8148-A5B9A73EF0D4Q38730160-5A924C75-AA7E-4B41-86C1-43337EB26A98Q38760452-3CB85EDD-997A-4411-B0DE-F99639758EF9Q38823179-38291887-84F3-4B3B-AA67-4F47079B8CCDQ39585070-A15EFF07-A23A-404F-AEF7-2EA5745EA45CQ39678707-357728E7-FF6D-4574-8307-668E90464AD8Q40128947-04148101-6BE1-4CC3-B912-5BE82E331FC2Q47754576-ECE93460-78D0-49C1-9E9C-F5AA4D24DF7DQ49843616-68B87B40-E095-4CBC-BD39-7BF3C443A82DQ50217787-C1FA5B58-818A-43DA-B6EF-9542DBFDE771Q54937050-B979814B-46A0-49BC-9585-3733284EEA26Q58760423-D77D03D1-A3B8-497C-A973-67209045926BQ59133970-8050F5DB-5281-4238-821B-E4DA8BB46321
P2860
Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Inhibition of HIF-1α by PX-478 ...... creatic ductal adenocarcinoma.
@ast
Inhibition of HIF-1α by PX-478 ...... creatic ductal adenocarcinoma.
@en
type
label
Inhibition of HIF-1α by PX-478 ...... creatic ductal adenocarcinoma.
@ast
Inhibition of HIF-1α by PX-478 ...... creatic ductal adenocarcinoma.
@en
prefLabel
Inhibition of HIF-1α by PX-478 ...... creatic ductal adenocarcinoma.
@ast
Inhibition of HIF-1α by PX-478 ...... creatic ductal adenocarcinoma.
@en
P2093
P2860
P356
P1433
P1476
Inhibition of HIF-1α by PX-478 ...... ncreatic ductal adenocarcinoma
@en
P2093
Chongbiao Huang
Tiansuo Zhao
P2860
P304
P356
10.18632/ONCOTARGET.2948
P407
P50
P577
2015-02-01T00:00:00Z